CasKAS: direct profiling of genome-wide dCas9 and Cas9 specificity using ssDNA mapping

Genome Biol. 2023 Apr 21;24(1):85. doi: 10.1186/s13059-023-02930-z.

Abstract

Detecting and mitigating off-target activity is critical to the practical application of CRISPR-mediated genome and epigenome editing. While numerous methods have been developed to map Cas9 binding specificity genome-wide, they are generally time-consuming and/or expensive, and not applicable to catalytically dead CRISPR enzymes. We have developed CasKAS, a rapid, inexpensive, and facile assay for identifying off-target CRISPR enzyme binding and cleavage by chemically mapping the unwound single-stranded DNA structures formed upon binding of a sgRNA-loaded Cas9 protein. We demonstrate this method in both in vitro and in vivo contexts.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • CRISPR-Associated Protein 9 / genetics
  • CRISPR-Cas Systems*
  • DNA, Single-Stranded* / genetics
  • Epigenome
  • Gene Editing / methods
  • Genome

Substances

  • DNA, Single-Stranded
  • CRISPR-Associated Protein 9